Oksaliplatin Sun (Oxaliplatin)

Oxaliplatin, the active ingredient in Oksaliplatin Sun, is a platinum‑based chemotherapy agent presented as a sterile solution for intravenous infusion use. It is employed in the treatment of colorectal cancer and related solid tumours in adult patients. GNH USA supplies Oksaliplatin Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Oksaliplatin Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Oxaliplatin is an antineoplastic ​​​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​ ​ ​ ​ ​ ​ ​ ​​  ​  ​  ​ ​  ​ ​  ​ ​   …

- Colorectal cancer: improves survival when combined with fluoropyrimidine‑based regimens. - Gastric cancer: used in combination protocols for advanced disease. - Pancreatic cancer: part of multi‑drug regimens in selected cases. - Metastatic solid tumours: incorporated into clinical trial‑based combination therapies. - Peri‑operative treatment of colorectal tumours with curative intent (Adjuvant therapy post‑surgery).

Oxaliplatin may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Nausea and vomiting: frequent during or shortly after infusion. - Peripheral neuropathy: tingling or numbness, often cumulative. - Diarrhoea: may range from mild to moderate. - Fatigue: generalised tiredness during treatment cycles. - Thrombocytopenia: reduced platelet count observed in blood tests.

Serious or Rare Side Effects: - Severe hypersensitivity reactions: anaphylaxis or bronchospasm. - Acute neurotoxicity: sudden onset of muscle cramps or jaw tightness. - Hemolytic‑uremic syndrome: rare renal‑related complication. - Severe neutropenia: marked drop in neutrophil count increasing infection risk. - Cardiotoxicity: uncommon arrhythmias or myocardial injury.

Oxaliplatin should be administered ​ ​  ​  ​   ​  ​   ​   ​   

- Monitor     g   t   d  d  ewline  ewline \n ewline  ewline ... ... ... ... ... ... ... ... ...  \

...